The Combined Use of in Silico, in Vitro, and in Vivo Analyses to Assess Anti-cancerous Potential of a Bioactive Compound from Cyanobacterium Nostoc sp. MGL001

The Combined Use of in Silico, in Vitro, and in Vivo Analyses to Assess Anti-cancerous Potential of a Bioactive Compound from Cyanobacterium Nostoc sp. MGL001

Escalating incidences of cancer, especially in developed and developing countries, demand evaluation of potential unexplored natural drug resources. Here, anticancer potential of 9-Ethyliminomethyl-12-(morpholin-4-ylmethoxy)-5,8,13,16-tetraaza -hexacene-2,3-dicarboxylic acid (EMTAHDCA) isolated from...

Full description

Bibliographic Details
Main Authors: Niveshika, Ekta Verma, Shashank K. Maurya, Rajnikant Mishra, Arun K. Mishra
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-11-01
Series:Frontiers in Pharmacology
Subjects:
EMTAHDCA
anticancer drug potential
in silico
in vivo
in vitro analysis
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00873/full

Internet

http://journal.frontiersin.org/article/10.3389/fphar.2017.00873/full

Similar Items